SCHEMBL139908

SCHEMBL139908

CC(C)CCCCCCN(CCCCCCC(C)C)CCCCCCC(C)C

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.48
KDM4C Q9H3R0 2/20 0.39
KDM4A O75164 1/20 0.39
PHF8 Q9UPP1 1/20 0.39
KDM2A Q9Y2K7 1/20 0.39
PLA2G1B P04054 1/20 0.38
PLA2G2A P14555 1/20 0.38
SIGMAR1 Q99720 1/20 0.35
ALDH1A1 P00352 2/20 0.33
TSHR P16473 1/20 0.33
HIF1A Q16665 1/20 0.33
EPAS1 Q99814 1/20 0.33
TRPV1 Q8NER1 1/20 0.31
TRPA1 O75762 1/20 0.31
BLM P54132 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1507499 1.00 LMNA (0.48) LMNAKDM4CKDM4APHF8KDM2A
SCHEMBL1507403 1.00 LMNA (0.48) LMNAKDM4CKDM4APHF8KDM2A
SCHEMBL1507275 1.00 LMNA (0.48) LMNAKDM4CKDM4APHF8KDM2A
SCHEMBL1507508 1.00 LMNA (0.48) LMNAKDM4CKDM4APHF8KDM2A
SCHEMBL8464998 1.00 LMNA (0.48) LMNAKDM4CKDM4APHF8KDM2A
SCHEMBL5189457 1.00 LMNA (0.48) LMNAKDM4CKDM4APHF8KDM2A
SCHEMBL1507494 1.00 LMNA (0.48) LMNAKDM4CKDM4APHF8KDM2A
SCHEMBL1020474 1.00 LMNA (0.48) LMNAKDM4CKDM4APHF8KDM2A
SCHEMBL1507539 1.00 LMNA (0.48) LMNAKDM4CKDM4APHF8KDM2A
SCHEMBL1507578 1.00 LMNA (0.48) LMNAKDM4CKDM4APHF8KDM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630572-B2 Method for preparing sulfonated arylphosphine Hanwha Solutions Corporation (KR) 2026-05-19 US claimed
US-20230416285-A1 METHOD FOR PREPARING SULFONATED ARYLPHOSPHINE Hanwha Solutions Corporation (KR) 2023-12-28 US claimed
EP-4238978-A1 METHOD FOR PREPARING SULFONATED ARYLPHOSPHINE Hanwha Solutions Corporation (KR) 2023-09-06 EP claimed
WO-2022092825-A1 METHOD FOR PREPARING SULFONATED ARYLPHOSPHINE 한화솔루션 주식회사 2022-05-05 WO claimed
CN-114316897-A Silicone sealant and preparation method thereof 广东高士高科实业有限公司 2022-04-12 CN claimed
US-6951960-B2 Method for removing impurities from solvent extraction solutions INCO LIMITED (CA) 2005-10-04 US claimed
US-20040014589-A1 Method for removing impurities from solvent extraction solutions GORO NICKEL S.A. (FR) 2004-01-22 US claimed
US-6083470-A PURIFIED BY EXTRACTION WITH AN AMINE HOECHST AKTIENGESELLSCHAFT (DE) 2000-07-04 US claimed
EP-0811424-A2 Catalyst systems based on Rhodium complexes with diphosphine ligands and their use for the preparation of aldehydes HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-10 EP claimed
EP-0807636-A1 Substituted diphosphines and process for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP claimed
EP-0490221-B1 Method for the production of unsaturated ethers HOECHST AG (DE) 1995-08-09 EP claimed
US-4504588-A Process for the recovery of water-soluble hydroformylation catalysts containing rhodium RUHRCHEMIE AKTIENGESELLSCHAFT (DE) 1985-03-12 US claimed
US-4435603-A MIXING WITH TERTIARY AMINES RUHRCHEMIE AKTIENGESELLSCHAFT (DE) 1984-03-06 US claimed
US-4385036-A ALKYLAMINE PHOSPHATE SOLVENT EXTRACTION CHEMISCHE FABRIK BUDENHEIM (DE) 1983-05-24 US claimed
US-4383978-A ALKYLAMINE-POLYPHOSPHATE SALT, SOLVENT EXTRACTION CHEMISCHE FABRIK BUDENHEIM (DE) 1983-05-17 US claimed
US-4283386-A APPLYING A CYSTEIC ACID COMPOUND AND A METALLIC COMPOUND SCOTT EUGENE J VAN 1981-08-11 US claimed
US-4224339-A Treatment of disturbed keratinization SCOTT EUGENE J VAN 1980-09-23 US claimed
US-3944606-A Process of producing alkali metal or ammonium citrates JOH. A. BENCKISER GMBH (DT) 1976-03-16 US claimed
US-12630572-B2 Method for preparing sulfonated arylphosphine Hanwha Solutions Corporation (KR) 2026-05-19 US disclosed
US-3944606-A Process of producing alkali metal or ammonium citrates JOH. A. BENCKISER GMBH (DT) 1976-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630572-B2 Method for preparing sulfonated arylphosphine TST, TPR, ALK LMNA 4848/4885KDM4C 924/4885KDM4A 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.